Future Journal of Pharmaceutical Sciences

Table 2 Precision table of Tezacaftor in Mobile phase and Human plasma

From: A rapid RP-HPLC method for the simultaneous estimation of Ivacaftor and Tezacaftor and in silico study of their metabolitic products

S. no.	Conc (μg/mL)	Mobile phase			Human plasma
S. no.	Conc (μg/mL)	Conc found (μg/mL)	%	Avg %	Conc found (μg/mL)	%	Avg %
1	30	30.9	103	102.5	30.12	100.4	99.66
2		30.63	102.1		29.96	99.86
3		30.64	102.1		29.99	99.96
4		30.70	102.3		29.84	99.46
5		30.90	103		29.68	98.93
6		30.83	102.7		29.82	99.4
S.D	0.05			0.098
% R.S.D	0.16			0.32

Back to article page